'%2F%3E%3Cpath%20d%3D'M6.5%2025%2016%207%2025.5%2025'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.8'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'16'%20cy%3D'19'%20r%3D'3.2'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
GROARC INDUSTRIES INDIA LIMITE
GROARC (BSE 532315) · ISIN INE042B01012 · Software Products · Est. 1992 · listed 2000 · website
Not on any surveillance list
Next: Board meeting: financial results on 2 November 2026.
Quarterly results
No quarterly results stored for this company yet.
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹40.21 cr | ₹0 cr | ₹42.38 cr |
| 30 Sep 2025 standalone | ₹38.86 cr | ₹1.49 cr | ₹40.87 cr |
| 31 Mar 2025 standalone | ₹39.86 cr | ₹1.49 cr | ₹41.94 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 0.00% | — | 0.00% | 100.00% |
Latest filings
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Chandran Ganesan 3 September 2026 · BSE
- ENCLOSED HEREWITH FINANCIAL RESULTS FOR QUARTER ENDED 30/06/2026 ALONGWITH LRR 6 August 2026 · BSE
- ENCLOSED HEREWITH OUTCOME OF BOARD MEETING 6 August 2026 · BSE
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for C Devasena 1 August 2026 · BSE
- Enclosed herewith Scrutinizer Report and Voting Result of 34th Annual General Meeting held on 18-07-2026 at 02:30 PM. 21 July 2026 · BSE
Other companies in Software Products
- Oracle Financial Services Software Limited
- Tanla Platforms Limited
- Nucleus Software Exports Limited
- C.E. Info Systems Limited
- Ramco Systems Limited
- Subex Limited
- Quick Heal Technologies Limited
- Capillary Technologies India Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.